🎁 Black Friday: up to 50% off of annual plans
Clinitech Laboratory Limited (BOM:544220)
India flag India · Delayed Price · Currency is INR
32.72
-1.43 (-4.19%)
At close: Nov 20, 2026

Clinitech Laboratory Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
138.3594.9182.3564.0363.4863.84
Revenue Growth
49.74%15.26%28.61%0.87%-0.58%40.19%
Cost of Revenue
53.0126.318.8113.7814.1418.18
Gross Profit
85.3468.6163.5450.2549.3345.66
Selling, General & Admin
39.4735.9132.9923.5320.3217.79
Other Operating Expenses
30.9322.5221.9316.7115.4917.19
Operating Expenses
76.0363.5359.4244.6340.2738.78
Operating Income
9.315.084.125.629.066.88
Interest Expense
-1.1-0.33-0.43-0.72-0.58-0.42
Interest & Investment Income
1.231.231.300.080.06
Earnings From Equity Investments
----0.040.11
Other Non Operating Income (Expenses)
-0.84-0.02-0.120.050.040.4
EBT Excluding Unusual Items
8.65.964.874.958.647.02
Gain (Loss) on Sale of Assets
--0.680.11--0
Pretax Income
8.65.965.555.058.647.02
Income Tax Expense
3.031.811.61.342.511.9
Earnings From Continuing Operations
5.574.153.953.716.135.13
Minority Interest in Earnings
-0.760.03----
Net Income
4.814.183.953.716.135.13
Net Income to Common
4.814.183.953.716.135.13
Net Income Growth
1.48%5.88%6.33%-39.45%19.61%27.39%
Shares Outstanding (Basic)
222222
Shares Outstanding (Diluted)
222222
Shares Change
3.30%9.65%32.88%4.44%--
EPS (Basic)
1.941.831.902.374.093.42
EPS (Diluted)
1.931.831.902.374.093.42
EPS Growth
-1.81%-3.49%-19.98%-42.03%19.61%27.39%

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-34.42-16.18-20.43-24.889.68-5.58
Free Cash Flow Per Share
-13.85-7.09-9.82-15.886.45-3.72
Gross Margin
61.68%72.29%77.16%78.47%77.72%71.52%
Operating Margin
6.73%5.35%5.00%8.77%14.27%10.77%
Profit Margin
3.48%4.40%4.79%5.80%9.66%8.03%
Free Cash Flow Margin
-24.88%-17.05%-24.81%-38.86%15.24%-8.73%
EBITDA
14.9210.168.599.9513.5210.69
EBITDA Margin
10.78%10.71%10.44%15.54%21.30%16.74%
D&A For EBITDA
5.615.084.474.344.463.81
EBIT
9.315.084.125.629.066.88
EBIT Margin
6.73%5.35%5.00%8.77%14.27%10.77%
Effective Tax Rate
35.21%30.41%28.84%26.52%29.02%27.00%
Revenue as Reported
139.4196.7984.6364.3963.6364.57
Advertising Expenses
-0.960.620.65--